不同的图表用于评估过早生长。芬顿图,基于产前生长,已在圣母大学医院的新生儿重症监护病房(NICU)中使用,以评估早产儿的发展。共生21是一个新的多学科,多民族增长图更好地适应过早的增长。我们的目标是比较Fenton和Intergrowth21两个图表,以便在我们的单位中实施Intergrowth。
我们分析了从2010年到2017年入住NICU的318份早产儿档案。人体测量数据(体重,身高和头围)从出生到1个月大的两个图表上都填写了百分位数。
线性回归的结果,以出生时的体重为因变量,结果表明,Fenton量表(R2=0.391)比Intergrowth21量表(R2=0.257)更好地预测出生时的体重。当作为因变量时,这同样适用于出生时的身高和颅骨周长。当考虑2周时的体重和身高时,结果表明,与Fenton量表相比,Intergrowth21量表能更好地预测这些变量,对于体重(0.384vs0.311)和身高(0.650vs0.585),较高的R2值较高,有利于Intergrowt21量表。4周时,结果表明,Fenton量表比Intergrowth21量表更好地预测体重(R2=0.655vs0.631)和身高(R2=0.710vs0.643)。所获得的结果根据新生儿的社会人口统计学和临床因素进行了调整。
我们的研究结果是有争议的,在2周龄和4周龄之前,芬顿生长图优于共生21,而Intergrowth21图表显示,在2个两周大时,体重和身高的百分位数高于Fenton图表。根据不同的设计进行进一步的研究,例如临床试验或前瞻性研究,应考虑考虑多个种族并在多个中心进行,以纳入更具代表性的黎巴嫩儿童样本,并能够将我们的结果推断到国家一级.
Different charts are used to assess premature growth. The
Fenton chart, based on prenatal growth, has been used in the neonates\' intensive care unit (NICU) of the Notre Dame des Secours University Hospital to assess premature newborns\' development. Intergrowth21 is a new multidisciplinary, multiethnic growth chart better adapted to premature growth. Our objective was to compare both charts
Fenton and Intergrowth21 in order to implement Intergrowth in our unit.
We analyzed 318 files of premature babies born who were admitted to the NICU from 2010 till 2017. Anthropometric data (weight, height and head circumference) converted to percentiles was filled on both charts from birth till 1 month of age.
The results of the linear regression, taking the weight at birth as the dependent variable, showed that the Fenton scale (R2 = 0.391) would predict the weight at birth better than the Intergrowth 21 scale (R2 = 0.257). The same applies for height and cranial perimeter at birth when taken as dependent variables. When considering the weight and height at 2 weeks, the results showed that the Intergrowth 21 scale would predict those variables better than the Fenton scale, with higher R2 values higher in favor of the Intergrowth 21 scale for both weight (0.384 vs 0.311) and height (0.650 vs 0.585). At 4 weeks, the results showed that the
Fenton scale would predict weight (R2 = 0.655 vs 0.631) and height (R2 = 0.710 vs 0.643) better than the Intergrowth 21 scale. The results obtained were adjusted over the newborns\' sociodemographic and clinical factors.
The results of our
study are controversial where the
Fenton growth charts are superior to Intergrowth 21 before 2 weeks of age and at 4 weeks, whereas Intergrowth 21 charts showed higher percentiles for weight and height than Fenton charts at 2 two weeks of age. Further studies following a different design, such as a clinical
trial or a prospective
study, taking multiple ethnicities into account and conducted in multiple centers should be considered to enroll a more representative sample of Lebanese children and be able to extrapolate our results to the national level.